The document discusses pleural effusion, including its normal physiology, pathogenesis, clinical manifestations, aetiology, investigations, and medical management. Pleural effusion occurs when fluid formation in the pleural space increases or absorption decreases, causing fluid accumulation. Effusions can be transudative or exudative. Investigations include chest x-ray, ultrasound, and thoracentesis for diagnostic and therapeutic purposes. Management involves treating the underlying cause, therapeutic thoracentesis for symptom relief, and procedures for recurrent or complicated effusions.
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Pleural effusion dr magdi sasi
1. 1 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
PLEURAL EFFUSION
Normal Physiology :
• Normally pleural space contains a thin layer of fluid.
• The pleural space is not really a space but rather a potential space
between the lung and chest wall.
• There is normally a very thin layer of fluid (from 2 to 10 m thick)
between the two pleural surfaces, the parietal pleura and visceral pleura
• During each respiratory cycle the pleural pressures and the geometry of
the pleural space fluctuate widely. Fluid enters and leaves the pleural
space constantly .
• Fluid enters the pleural space from the capillaries in the parietal pleural
and is removed by the lymphatics in the parietal pleura.
• Fluid can also enter the pleural space from the interstitial spaces of the
lung via the visceral pleura or from the peritoneal cavity through the
diaphragm.
PATHOGENESIS:
• Pleural fluid accumulates when
Formation increases
Absorption decreases
• Pleural effusion can be
Transudative
Exudative
• Transudative effusion occurs due to systemic factors which either
increase the hydrostatic pressure or decrease the plasma oncotic
pressure( decrease albumin).
2. 2 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
• Exudative effusion occurs due to local pathology in the lung or the pleura.
Clinical Manifestations
The symptoms of a patient with a pleural effusion are
to a large extent dictated by the underlying process
causing the effusion.
Many patients have no symptoms referable to the
effusion when effusion is small.
When symptoms are related to the effusion, they arise
either from inflammation of the pleura or from
compromise of pulmonary mechanics.
Pleuritic chest pain is the usual symptom of pleural
inflammation.
Irritation of the pleural surfaces may also result in a dry,
nonproductive cough.
With larger effusions, dyspnea results from lung
compression. 15Dr. Canmao xie
Physical Examinations:
Signs are closely correlated to the volume of pleural effusions. The
volume is larger, the signs is obviously.
Physical examination of a patient
with pleural effusion reveals :
Decreased or absent tactile
fremitus, stony dullness to
percussion
Diminished breath sounds over the
site of the effusion
Bronchial breath sounds are
frequently present immediately
above the effusion due to lung
collapse.
4. 4 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
INVESTIGATION:
Radiological examination
The first fluid accumulates in the lowest portion of the thoracic cavity,
which is the posterior costophrenic angle. Therefore, the earliest
radiologic sign of a pleural effusion is blunting of the posterior
costophrenic angle on the lateral chest radiograph.
If a posteroanterior radiograph is obtained with the patient lying on the
affected side, free pleural fluid will gravitate inferiorly and a pleural fluid
line will be visible.
Types of Pleural Effusion on X-ray:
1. Free fluid in the pleural space
a. Lamellar effusion
b. Subpulmonary effusion
c. Fissural effusion
2. Loculated effusion
3. Massive pleural effusion
5. 5 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
Free fluid
1. First appears in the posterior CP angle (100-200ml fluid): Lateral film
blunting of the posterior costophrenic angle
2. Meniscus sign:
– Dense homogenous opacity
– Well defined concave upper edge
– Higher laterally than medially
– Obscures the diaphragmatic shadow
Loculated effusion
1. No change by gravitational methods
2. ?Extrapleural opacity, ?Peripheral lung lesion
3. Pleural fluid is said to be loculated when it does not shift freely in the
pleural space as the patient’s position is changed. Loculated pleural
6. 6 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
effusions occur when there are adhesions between the visceral and
parietal pleurae.
Fissural effusion:
1. Lenticular, round or oval shadow
2. “Thickened” fissure
3. ‘Pseudo’ or ‘ Vanishing’ tumors?
Also look for?
1. Positioning?
2. Breast shadows?
3. Rib: Erosions, #
4. Trachea: Shift, Paratracheal shadows
5. Cardiac shadow
6. Lung fields: Cavity, “cotton wool” infiltrates,
Cannon ball mets
7. Hilum: Lymphadenopathy
8. Air-fluid level
9. Pleura: Masses, thickening.
7. 7 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
Massive Pleural effusion
1. White out lung(WOL) + Contralateral Mediastinal shift
D/D:
1. Collapse (WOL + Ipsilateral Mediastinal Shift)
2. Consolidation (WOL + Central trachea)
8. 8 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
Ultrasonography
• Detects even 5ml of fluid in excess on normal
• Differentiation of pleural thickening from loculated pleural effusion
• Associated abnormalities
Pleural aspiration and Analysis
Transudative or Exudative?
LIGHT’S CRITERIA:
1. Pleural fluid protein/Serum Protein >0.5
2. Pleural fluid LDH/Serum LDH >0.6
3. Pleural fluid LDH > 2/3rd
the upper limit of serum LDH
Tuberculous effusion
1. “Amber” coloured to sero-sanguineous
2. >10%eosinophils; <5%: Mesothelial cells
3. Centrifuged deposits:
– AFB +ve: <10% immunocompetent host
– Culture +ve: 25%
4. ADA elevated (>40U/L)
5. Others: LDH, Soluble IL-2 receptors, IFN-γ
6. Detection of Mycobacteria DNA by PCR
7. Nucleic acid amplification assays
8. Pleural biopsy: Non-caseating granulomas > 80%
9. 9 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
MEDICAL MANAGEMNT
Treatment of underlying cause
Therapeutic aspiration is necessary in order to relieve dyspnoea
Precautions:
Removing more than 1L in one episode in inadvisable
Can result in re-expansion pulmonary oedema
Should never be aspirated to dryness before the exact etiology is determined
THORACOCENTESIS
INDICATIONS
Diagnostic
Therapeutic
POSITION
Sitting position, leaning
forward over a support
SITE
Below the scapula,
posteriorly through
the seventh
intercostal space
PROCEDURE
Informed consent
Clean the area with povidine iodine
Local anesthesia
10. 10 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
Insert the needle and flexible catheter over the needle
Aspirate pleural fluid
COMPLICATIONS
Iatrogenic pneumothorax
Infection
Dry tap or bloody tap
Re-expansion pulmonary oedema
Pain and respiratory distress
Effusion due to Heart Failure
• Most common cause of pleural effusion
• a diagnostic thoracentesis is done if:
– the effusions are not bilateral and comparable in size
– the patient is febrile
– the patient has pleuritic chest pain to verify that the effusion is
transudative
• Otherwise the patient's heart failure is treated
• If the effusion persists despite therapy, a diagnosticthoracentesis should
be done
• A pleural fluid N-terminal pro-brain natriuretic peptide (NT-proBNP)
>1500 pg/mL is diagnostic of an effusion secondary to congestive heart
failure
11. 11 DR MAGDI AWAD SASI SIMPLE APPROACH TO PLEURAL EFFUSION 2014
Parapneumonic Effusions
• most common cause of exudative pleural effusion (bacterial pneumonias,
lung abscess, bronchiectasis)
• The presence of free pleural fluid can be demonstrated with a lateral
decubitus radiograph, CT of the chest, or ultrasound
• If the free fluid separates the lung from the chest wall by >10 mm, a
therapeutic thoracocentesis should be performed
• A procedure more invasive than thoracocentesis is needed if the following
factors are present:
– Loculated pleural fluid
– Pleural fluid pH <7.20
– Pleural fluid glucose <3.3 mmol/L (<60 mg/dL)
– Positive Gram stain or culture of the pleural fluid
– Presence of gross pus in the pleural space
• If the fluid recurs after the initial therapeutic thoracentesis and if any of
these characteristics are present - a repeat thoracentesis
• If the fluid cannot be completely removed with the therapeutic
thoracentesis,
• insert a chest tube and instill a fibrinolytic agent (e.g., tissue plasminogen
activator, 10 mg)
• perform a thoracoscopy with the breakdown of adhesions
• Decortication (if these measures are ineffective)